These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 17699257

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. C4d positivity is often associated with acute cellular rejection in renal transplant biopsies following Campath-1H (Alemtuzumab) induction.
    Zhang PL, Malek SK, Blasick TM, Pennington JR, Masker KK, Lun M, Potdar S.
    Ann Clin Lab Sci; 2007; 37(2):121-6. PubMed ID: 17522366
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
    Lü TM, Yang SL, Wu WZ, Tan JM.
    Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
    [Abstract] [Full Text] [Related]

  • 5. Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation.
    Pascual J, Pirsch JD, Odorico JS, Torrealba JR, Djamali A, Becker YT, Voss B, Leverson GE, Knechtle SJ, Sollinger HW, Samaniego-Picota MD.
    Transplantation; 2009 Jan 15; 87(1):125-32. PubMed ID: 19136902
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Monocyte-mediated acute renal rejection after combined treatment with preoperative Campath-1H (alemtuzumab) and postoperative immunosuppression.
    Zhang PL, Malek SK, Prichard JW, Lin F, Yahya TM, Schwartzman MS, Latsha RP, Skaletsky M, Norfolk ER, Brown RE, Hartle JE, Potdar S.
    Ann Clin Lab Sci; 2004 Jan 15; 34(2):209-13. PubMed ID: 15228236
    [Abstract] [Full Text] [Related]

  • 8. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).
    Kirk AD, Hale DA, Mannon RB, Kleiner DE, Hoffmann SC, Kampen RL, Cendales LK, Tadaki DK, Harlan DM, Swanson SJ.
    Transplantation; 2003 Jul 15; 76(1):120-9. PubMed ID: 12865797
    [Abstract] [Full Text] [Related]

  • 9. Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells.
    Morales J, Bono MR, Fierro A, Iñiguez R, Zehnder C, Rosemblatt M, Calabran L, Herzog C, Benavente D, Aguiló J, Pefaur J, Alba A, Ferrario M, Simon W, Contreras L, Buckel E.
    Transplant Proc; 2008 Nov 15; 40(9):3223-8. PubMed ID: 19010240
    [Abstract] [Full Text] [Related]

  • 10. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ.
    Transplantation; 2009 Sep 27; 88(6):810-9. PubMed ID: 19920781
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Alemtuzumab induction in deceased donor kidney transplantation.
    Shin M, Song SH, Kim JM, Kwon CH, Joh JW, Lee SK, Kim SJ.
    Transplant Proc; 2011 Sep 27; 43(6):2365-78. PubMed ID: 21839271
    [Abstract] [Full Text] [Related]

  • 14. Alemtuzumab induction in kidney transplantation.
    Huang E, Cho YW, Shah T, Peng A, Hayashi R, Bunnapradist S.
    Clin Transpl; 2005 Sep 27; ():343-54. PubMed ID: 17424750
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunophenotyping of interstitial infiltrate does not distinguish between BK virus nephropathy and acute cellular rejection.
    Rogers NM, Russ GR, Cooper J, Coates PT.
    Nephrology (Carlton); 2009 Feb 27; 14(1):118-22. PubMed ID: 19143944
    [Abstract] [Full Text] [Related]

  • 18. Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion.
    Kayler LK, Lakkis FG, Morgan C, Basu A, Blisard D, Tan HP, McCauley J, Wu C, Shapiro R, Randhawa PS.
    Am J Transplant; 2007 Apr 27; 7(4):949-54. PubMed ID: 17331114
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.